Verition Fund Management’s QuidelOrtho QDEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-13,084
Closed -$215K 2430
2026
Q1
$215K Sell
13,084
-10,216
-44% -$251K ﹤0.01% 1928
2025
Q4
$665K Sell
23,300
-46,436
-67% -$1.26M ﹤0.01% 2455
2025
Q3
$2.05M Buy
69,736
+24,031
+53% +$657K 0.01% 1958
2025
Q2
$1.32M Sell
45,705
-53,173
-54% -$1.57M 0.01% 2260
2025
Q1
$3.46M Buy
98,878
+92,053
+1,349% +$3.75M 0.02% 1145
2024
Q4
$304K Buy
+6,825
New +$279K ﹤0.01% 2774
2023
Q3
Sell
-2,568
Closed -$213K 2619
2023
Q2
$213K Buy
+2,568
New +$225K ﹤0.01% 1810
2023
Q1
Sell
-4,089
Closed -$350K 2484
2022
Q4
$350K Buy
4,089
+968
+31% +$82K 0.01% 1415
2022
Q3
$223K Sell
3,121
-589
-16% -$52.7K ﹤0.01% 2435
2022
Q2
$361K Buy
+3,710
New +$378K 0.01% 1637
2021
Q2
Sell
-2,422
Closed -$310K 2086
2021
Q1
$310K Buy
+2,422
New +$447K ﹤0.01% 1102
2019
Q2
Sell
-6,191
Closed -$405K 1311
2019
Q1
$405K Buy
6,191
+506
+9% +$30.6K 0.02% 731
2018
Q4
$278K Sell
5,685
-2,043
-26% -$122K 0.02% 645
2018
Q3
$504K Buy
7,728
+2,260
+41% +$158K 0.02% 840
2018
Q2
$364K Buy
+5,468
New +$330K 0.02% 794

Other funds holding QDEL

Verition Fund Management's QDEL Position: Q2 2026 in Review

Verition Fund Management sold out of QuidelOrtho (QDEL) in Q2 2026, closing a stake of 13,084 shares — an estimated $215K sold.

Verition Fund Management first reported a position in QDEL in Q2 2018 and held it in 15 quarters. The position peaked at $3.46M in Q1 2025. 245 funds tracked by Wall St. Rank hold QDEL as of Q2 2026.

  • Verition Fund Management reported no remaining QuidelOrtho position as of Q2 2026 after selling out during the quarter.
  • Verition Fund Management sold 13,084 QuidelOrtho shares in Q2 2026, an estimated $215K.
  • Verition Fund Management first reported a position in QuidelOrtho in Q2 2018 and held it in 15 quarters.
  • Verition Fund Management's QuidelOrtho position peaked at $3.46M in Q1 2025.
  • 245 funds tracked by Wall St. Rank held QuidelOrtho as of Q2 2026.

Based on Verition Fund Management's 13F filing for Q2 2026, filed 14 Aug 2026.